129 related articles for article (PubMed ID: 11749972)
1. Biochemical and structural studies of the prion protein polymorphism.
Petchanikow C; Saborio GP; Anderes L; Frossard MJ; Olmedo MI; Soto C
FEBS Lett; 2001 Dec; 509(3):451-6. PubMed ID: 11749972
[TBL] [Abstract][Full Text] [Related]
2. The presence of valine at residue 129 in human prion protein accelerates amyloid formation.
Baskakov I; Disterer P; Breydo L; Shaw M; Gill A; James W; Tahiri-Alaoui A
FEBS Lett; 2005 May; 579(12):2589-96. PubMed ID: 15862295
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
Downing DT; Lazo ND
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
[TBL] [Abstract][Full Text] [Related]
5. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
6. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
[TBL] [Abstract][Full Text] [Related]
7. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
Jones EM; Surewicz K; Surewicz WK
J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
[TBL] [Abstract][Full Text] [Related]
8. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
9. Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation.
Lewis PA; Tattum MH; Jones S; Bhelt D; Batchelor M; Clarke AR; Collinge J; Jackson GS
J Gen Virol; 2006 Aug; 87(Pt 8):2443-2449. PubMed ID: 16847141
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease.
Apostol MI; Sawaya MR; Cascio D; Eisenberg D
J Biol Chem; 2010 Sep; 285(39):29671-5. PubMed ID: 20685658
[TBL] [Abstract][Full Text] [Related]
11. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
[TBL] [Abstract][Full Text] [Related]
12. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
13. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
Yamaguchi K; Matsumoto T; Kuwata K
Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
[TBL] [Abstract][Full Text] [Related]
14. The codon for the methionine at position 129 (M129) in the human prion protein provides an alternative initiation site for translation and renders individuals homozygous for M129 more susceptible to prion disease.
Concepcion GP; Padlan EA
Med Hypotheses; 2005; 65(5):865-7. PubMed ID: 16081222
[TBL] [Abstract][Full Text] [Related]
15. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants.
Kirby L; Agarwal S; Graham JF; Goldmann W; Gill AC
Biochemistry; 2010 Feb; 49(7):1448-59. PubMed ID: 20085368
[TBL] [Abstract][Full Text] [Related]
17. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism.
Monari L; Chen SG; Brown P; Parchi P; Petersen RB; Mikol J; Gray F; Cortelli P; Montagna P; Ghetti B
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2839-42. PubMed ID: 7908444
[TBL] [Abstract][Full Text] [Related]
18. Secondary-structure prediction revisited: Theoretical β-sheet propensity and coil propensity represent structures of amyloids and aid in elucidating phenomena involved in interspecies transmission of prions.
Taguchi Y; Nishida N
PLoS One; 2017; 12(2):e0171974. PubMed ID: 28199368
[TBL] [Abstract][Full Text] [Related]
19. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
20. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
